文献速递妇科产科

大规模荟萃分析:乳腺/卵巢癌相关基因组套检测所识别突变的癌症易感基因证据

Large-scale meta-analysis of mutations identified in panels of breast/ovarian cancer-related genes - Providing evidence of cancer predisposition genes.
PubMed 文献 · Gynecol Oncol · 2019-02-04

该研究对48项基于多基因组套检测(MGP)分析乳腺癌(BC)/卵巢癌(OC)患者的研究进行荟萃分析,评估37个基因的作用,比较约12万例BC/OC病例与约12万例对照的突变频率。结果显示13个基因与BC风险升高显著相关、11个基因与OC风险升高显著相关,部分基因(如CDKN2A、PALB2对BC)的风险与BRCA2相似,且BC与OC的贡献基因谱存在实质性差异。

要点

  • 13个基因与乳腺癌风险升高显著相关,11个基因与卵巢癌风险升高显著相关。
  • CDKN2A和PALB2对乳腺癌的风险与BRCA2相似。
  • RAD51C和RAD51D与卵巢癌高风险相关但不与乳腺癌相关。

核心结论

  • 该研究提供了强有力的统计学证据,明确了多个常被视为BC/OC易感候选基因的风险,并排除了其他常在MGP中分析的基因的作用。
  • 在临床诊断背景下,结果支持对已识别突变进行基于知识的解读。

研究设计与样本

  • 研究为对48项基于MGP分析BC/OC患者的研究进行的综合荟萃分析。
  • 评估了37个基因的作用,共比较约120,000例BC/OC病例与约120,000例对照的突变频率。

主要发现

  • 13个分析基因与BC风险升高显著相关,11个分析基因与OC风险升高显著相关。
  • 部分基因(如CDKN2A和PALB2对BC)的风险与BRCA2相似。
  • BC与OC的贡献基因谱存在实质性差异,包括RAD51C和RAD51D与OC高风险相关但不与BC相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Germline mutations occurring in the highly penetrant genes BRCA1 and BRCA2 are responsible for only certain cases of familial breast cancer (BC) and ovarian cancer (OC). Thus, the use of NGS multi-gene panel (MGP) testing has recently become very popular. METHODS: To estimate a reliable BC and OC risk associated with pathogenic variants in the selected candidate BC/OC predisposition genes, a comprehensive meta-analysis of 48 MGP-based studies analyzing BC/OC patients was conducted. The role of 37 genes was evaluated, comparing, in total, the mutation frequency in ~120,000 BC/OC cases and ~120,000 controls, which guaranteed strong statistical support with high confidence for most analyzed genes. RESULTS: We characterized the strategies of MGP analyses and the types and localizations of the identified mutations and showed that 13 and 11 of the analyzed genes were significantly associated with an increased BC and OC risk, respectively. The risk attributed to some of these genes (e.g., CDKN2A and PALB2 for BC) was similar to that observed for BRCA2. The analysis also showed a substantial difference in the profile of genes contributing to either BC or OC risk, including genes specifically associated with a high risk of OC but not BC (e.g., RAD51C, and RAD51D). CONCLUSIONS: Our study provides strong statistical proof, defines the risk for many genes often considered candidates for BC/OC predisposition and excludes the role of other genes frequently analyzed in the MGPs. In the context of clinical diagnostics, the results support the knowledge-based interpretation of identified mutations.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Suszynska M, Klonowska K, Jasinska AJ, et al. Large-scale meta-analysis of mutations identified in panels of breast/ovarian cancer-related genes - Providing evidence of cancer predisposition genes. Gynecol Oncol. 2019. PMID: 30733081. doi:10.1016/j.ygyno.2019.01.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。